Search Results - "Janus"

Tumour‐induced alterations in single‐nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolism by Samet Agca, Aylin Domaniku‐Waraich, Sevval Nur Bilgic, Melis Sucuoglu, Meric Dag, Sukru Anil Dogan, Serkan Kir

Connect to this object online.

Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin by Ahmad Nasrollahi S, Sabet Nematzadeh M, Samadi A, Ayatollahi A, Yadangi S, Abels C, Firooz A

Connect to this object online.

Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two interna... by Bianca M. Piraccini, Manabu Ohyama, Brittany Craiglow, Anthony Bewley, Yuxin Ding, Yun‐Fei Chen, Yves Dutronc, Evangeline Pierce, Frederick Durand, Arash Mostaghimi

Connect to this object online.

OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway by Xiao-Yan Luo, Qun Liu, Huan Yang, Qi Tan, Li-Qiang Gan, Fa-Liang Ren, Hua Wang

Connect to this object online.

Shuxie-1 Decoction Alleviated CUMS -Induced Liver Injury via IL-6/JAK2/STAT3 Signaling by Mengting Zhang, Wanhong Wu, Wanhong Wu, Caoxin Huang, Teng Cai, Nengjiang Zhao, Suhuan Liu, Shuyu Yang

Connect to this object online.

European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib by Kawalec P, Śladowska K, Malinowska-Lipień I, Brzostek T, Kózka M

Connect to this object online.

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis by Meyer Debra M, Jesson Michael I, Li Xiong, Elrick Mollisa M, Funckes-Shippy Christie L, Warner James D, Gross Cindy J, Dowty Martin E, Ramaiah Shashi K, Hirsch Jeffrey L, Saabye Matthew J, Barks Jennifer L, Kishore Nandini, Morris Dale L

Connect to this object online.

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients by Wei C, Zhang X, Liang D, Yang J, Du J, Yue C, Deng L

Connect to this object online.

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study by Nicolino Ruperto, Hermine I. Brunner, Zbigniew Zuber, Nikolay Tzaribachev, Daniel J. Kingsbury, Ivan Foeldvari, Gerd Horneff, Elzbieta Smolewska, Richard K. Vehe, Anasuya Hazra, Rong Wang, Charles A. Mebus, Christine Alvey, Manisha Lamba, Sriram Krishnaswami, Thomas C. Stock, Min Wang, Ricardo Suehiro, Alberto Martini, Daniel J. Lovell, for the Pediatric Rheumatology International Trials Organization (PRINTO), the Pediatric Rheumatology Collaborative Study Group (PRCSG)

Connect to this object online.

Avaliação do Perfil de Segurança do Baricitinib em Doentes com Artrite Reumatoide: Meta-análise de Ensaios Clínicos by Nuno Alexandre Abrunheiro, Carlos Alves, Francisco Batel Marques

Connect to this object online.

A Comparative Study on Adipose-Derived Mesenchymal Stem Cells Secretome Delivery Using Microneedling and Fractional CO2 Laser for Facial Skin Rejuvenation by Yusharyahya SN, Japranata VV, Sitohang IBS, Legiawati L, Novianto E, Suseno LS, Rachmani K

Connect to this object online.

Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study by Wang MJ, Zhao YH, Fan C, Wang YJ, Wang XQ, Qiu XJ, Shen RL

Connect to this object online.

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS) by Nobuo Kanazawa, Taeko Ishii, Yasushi Takita, Atsushi Nishikawa, Ryuta Nishikomori

Connect to this object online.

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2) by Eric L. Simpson, Vimal H. Prajapati, Yael A. Leshem, Raj Chovatiya, Marjolein S. de Bruin-Weller, Sonja Ständer, Andrew E. Pink, Brian M. Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M. Platt, Jonathan I. Silverberg

Connect to this object online.

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future by Navarini L, Currado D, Costa L, Tasso M, Chimenti MS, Caso F

Connect to this object online.

Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease by Ziyi Sun, Rongqi Li, Yingai Wang, Feng Han, Wei Wei, Xin Li

Connect to this object online.

More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis by Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, Jonathan I. Silverberg

Connect to this object online.

LncRNA-miRNA-mRNA expression variation profile in the urine of calcium oxalate stone patients by Xiongfa Liang, Yongchang Lai, Weizhou Wu, Dong Chen, Fangling Zhong, Jian Huang, Tao Zeng, Xiaolu Duan, Yapeng Huang, Shike Zhang, Shujue Li, Wenqi Wu

Connect to this object online.

Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis by Jixia Lin, Yougang Ren

Connect to this object online.

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis by Van De Laar CJ, Oude Voshaar MAH, Fakhouri WKH, Zaremba-Pechmann L, De Leonardis F, De La Torre I, Van De Laar MAFJ

Connect to this object online.